⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

OMER News

Omeros Corporation

Omeros Announces Publication Highlighting Survival Benefits in TA-TMA Patients Treated with Narsoplimab Versus a Well-Matched External Control Group